Herbalife (NYSE:HLF - Get Free Report) is expected to be posting its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect the company to post earnings of $0.6180 per share and revenue of $1.31 billion for the quarter. Individuals may review the information on the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Monday, November 2, 2026 at 5:00 PM ET.
Herbalife (NYSE:HLF - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.51 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.54 by ($0.03). The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.31 billion. Herbalife had a negative return on equity of 43.90% and a net margin of 3.16%. Herbalife's quarterly revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.59 earnings per share. On average, analysts expect Herbalife to post $2.68 EPS for the current fiscal year and $3.01 EPS for the next fiscal year.
Herbalife Stock Performance
Herbalife stock opened at $13.40 on Monday. The stock's 50 day simple moving average is $12.62 and its two-hundred day simple moving average is $12.99. The stock has a market cap of $1.40 billion, a price-to-earnings ratio of 8.65, a PEG ratio of 0.44 and a beta of 0.78. Herbalife has a fifty-two week low of $7.56 and a fifty-two week high of $20.40.
Herbalife declared that its board has authorized a share repurchase program on Tuesday, September 8th that permits the company to buy back $250.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 19.3% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's board believes its stock is undervalued.
Analyst Ratings Changes
HLF has been the subject of a number of research analyst reports. Citigroup restated a "buy" rating and issued a $17.00 target price (down from $21.00) on shares of Herbalife in a research note on Friday, August 7th. Wall Street Zen upgraded Herbalife from a "hold" rating to a "buy" rating in a research report on Saturday. Zacks Research raised Herbalife from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, September 30th. UBS Group set a $21.00 price objective on Herbalife in a report on Thursday, September 17th. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Herbalife in a report on Thursday. Two research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Herbalife presently has a consensus rating of "Moderate Buy" and a consensus price target of $17.67.
Get Our Latest Analysis on Herbalife
Herbalife Company Profile
(
Get Free Report)
Herbalife Ltd. NYSE: HLF is a global nutrition and wellness company that develops and distributes products through a network of independent members and distributors. Its offerings include meal-replacement shakes, protein and other dietary supplements, vitamins, sports nutrition products, and personal-care items.
Founded in 1980 by Mark Hughes, Herbalife sells its products through direct-selling channels rather than primarily through traditional retail stores. Independent distributors market the products, provide product guidance, and may operate nutrition clubs or similar community-based businesses.
The company serves customers across numerous markets in North America, Latin America, Europe, Asia-Pacific, and other regions.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.